ID   CP4Z1_HUMAN             Reviewed;         505 AA.
AC   Q86W10; Q5VVE4;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   28-JUN-2023, entry version 162.
DE   RecName: Full=Cytochrome P450 4Z1 {ECO:0000303|PubMed:29018033};
DE            EC=1.14.14.1 {ECO:0000269|PubMed:19090726, ECO:0000269|PubMed:29018033};
DE   AltName: Full=CYPIVZ1;
DE   AltName: Full=Laurate 7-monooxygenase {ECO:0000305|PubMed:19090726, ECO:0000305|PubMed:29018033};
DE            EC=1.14.14.130 {ECO:0000269|PubMed:19090726, ECO:0000269|PubMed:29018033};
GN   Name=CYP4Z1 {ECO:0000303|PubMed:19090726,
GN   ECO:0000312|HGNC:HGNC:20583}; ORFNames=UNQ3060/PRO9882;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15059886; DOI=10.1158/0008-5472.can-03-0849;
RA   Rieger M.A., Ebner R., Bell D.R., Kiessling A., Rohayem J., Schmitz M.,
RA   Temme A., Rieber E.P., Weigle B.;
RT   "Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with
RT   overexpression in breast carcinoma.";
RL   Cancer Res. 64:2357-2364(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=19090726; DOI=10.1515/bc.2009.030;
RA   Zoellner A., Dragan C.A., Pistorius D., Mueller R., Bode H.B., Peters F.T.,
RA   Maurer H.H., Bureik M.;
RT   "Human CYP4Z1 catalyzes the in-chain hydroxylation of lauric acid and
RT   myristic acid.";
RL   Biol. Chem. 390:313-317(2009).
RN   [6]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=29018033; DOI=10.1124/dmd.117.078188;
RA   McDonald M.G., Ray S., Amorosi C.J., Sitko K.A., Kowalski J.P., Paco L.,
RA   Nath A., Gallis B., Totah R.A., Dunham M.J., Fowler D.M., Rettie A.E.;
RT   "Expression and Functional Characterization of Breast Cancer-Associated
RT   Cytochrome P450 4Z1 in Saccharomyces cerevisiae.";
RL   Drug Metab. Dispos. 45:1364-1371(2017).
CC   -!- FUNCTION: A cytochrome P450 monooxygenase that catalyzes the in-chain
CC       oxidation of fatty acids (PubMed:19090726, PubMed:29018033). Catalyzes
CC       the hydroxylation of carbon-hydrogen bonds. Hydroxylates lauric and
CC       myristic acids predominantly at the omega-4 and omega-2 positions,
CC       respectively (PubMed:19090726, PubMed:29018033). Catalyzes the
CC       epoxidation of double bonds of polyunsaturated fatty acids (PUFA).
CC       Displays an absolute stereoselectivity in the epoxidation of
CC       arachidonic acid producing the 14(S),15(R)-epoxyeicosatrienoic acid
CC       (EET) enantiomer (PubMed:29018033). Mechanistically, uses molecular
CC       oxygen inserting one oxygen atom into a substrate, and reducing the
CC       second into a water molecule, with two electrons provided by NADPH via
CC       cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase)
CC       (PubMed:19090726, PubMed:29018033). {ECO:0000269|PubMed:19090726,
CC       ECO:0000269|PubMed:29018033}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an organic molecule + O2 + reduced [NADPH--hemoprotein
CC         reductase] = an alcohol + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:17149, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:30879, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:142491; EC=1.14.14.1;
CC         Evidence={ECO:0000269|PubMed:19090726, ECO:0000269|PubMed:29018033};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17150;
CC         Evidence={ECO:0000305|PubMed:19090726, ECO:0000305|PubMed:29018033};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanoate + O2 + reduced [NADPH--hemoprotein reductase] = 7-
CC         hydroxydodecanoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:45084, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:18262, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:84921; EC=1.14.14.130;
CC         Evidence={ECO:0000269|PubMed:19090726, ECO:0000269|PubMed:29018033};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45085;
CC         Evidence={ECO:0000305|PubMed:19090726, ECO:0000305|PubMed:29018033};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanoate + O2 + reduced [NADPH--hemoprotein reductase] = 8-
CC         hydroxydodecanoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:66888, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:18262, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:167541; Evidence={ECO:0000269|PubMed:19090726,
CC         ECO:0000269|PubMed:29018033};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66889;
CC         Evidence={ECO:0000305|PubMed:19090726, ECO:0000305|PubMed:29018033};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanoate + O2 + reduced [NADPH--hemoprotein reductase] = 9-
CC         hydroxydodecanoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:66872, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:18262, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:167543; Evidence={ECO:0000269|PubMed:19090726,
CC         ECO:0000269|PubMed:29018033};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66873;
CC         Evidence={ECO:0000305|PubMed:19090726, ECO:0000305|PubMed:29018033};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanoate + O2 + reduced [NADPH--hemoprotein reductase] =
CC         10-hydroxydodecanoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:66892, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:18262, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:167542; Evidence={ECO:0000269|PubMed:19090726,
CC         ECO:0000269|PubMed:29018033};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66893;
CC         Evidence={ECO:0000305|PubMed:19090726, ECO:0000305|PubMed:29018033};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanoate + O2 + reduced [NADPH--hemoprotein reductase] =
CC         11-hydroxydodecanoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:39751, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:18262, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:76628; Evidence={ECO:0000269|PubMed:29018033};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39752;
CC         Evidence={ECO:0000305|PubMed:29018033};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + reduced [NADPH--hemoprotein reductase] + tetradecanoate =
CC         9-hydroxytetradecanoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:66916, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:30807, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:167544; Evidence={ECO:0000269|PubMed:29018033};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66917;
CC         Evidence={ECO:0000305|PubMed:29018033};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + reduced [NADPH--hemoprotein reductase] + tetradecanoate =
CC         10-hydroxytetradecanoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:66880, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:30807, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:167545; Evidence={ECO:0000269|PubMed:19090726};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66881;
CC         Evidence={ECO:0000305|PubMed:19090726};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + reduced [NADPH--hemoprotein reductase] + tetradecanoate =
CC         11-hydroxytetradecanoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:66884, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:30807, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:167547; Evidence={ECO:0000269|PubMed:19090726};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66885;
CC         Evidence={ECO:0000305|PubMed:19090726};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + reduced [NADPH--hemoprotein reductase] + tetradecanoate =
CC         12-hydroxytetradecanoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:66876, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:30807, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:167546; Evidence={ECO:0000269|PubMed:19090726};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66877;
CC         Evidence={ECO:0000305|PubMed:19090726};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 + reduced
CC         [NADPH--hemoprotein reductase] = (14S,15R)-epoxy-(5Z,8Z,11Z)-
CC         eicosatrienoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:49856, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:32395, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:131964; Evidence={ECO:0000269|PubMed:29018033};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:49857;
CC         Evidence={ECO:0000305|PubMed:29018033};
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000250|UniProtKB:Q02928};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:15059886}; Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:15059886}. Microsome membrane
CC       {ECO:0000269|PubMed:15059886}; Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:15059886}.
CC   -!- TISSUE SPECIFICITY: Preferentially detected in breast carcinoma tissue
CC       and mammary gland, whereas only marginal expression is found in all
CC       other tested tissues. {ECO:0000269|PubMed:15059886}.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY262056; AAO89257.1; -; mRNA.
DR   EMBL; AY358631; AAQ88994.1; -; mRNA.
DR   EMBL; AK292175; BAF84864.1; -; mRNA.
DR   EMBL; AL450996; CAH71036.1; -; Genomic_DNA.
DR   EMBL; AL135960; CAH71036.1; JOINED; Genomic_DNA.
DR   EMBL; AL135960; CAI19734.1; -; Genomic_DNA.
DR   EMBL; AL450996; CAI19734.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS545.1; -.
DR   RefSeq; NP_835235.1; NM_178134.2.
DR   AlphaFoldDB; Q86W10; -.
DR   SMR; Q86W10; -.
DR   STRING; 9606.ENSP00000334246; -.
DR   BindingDB; Q86W10; -.
DR   ChEMBL; CHEMBL4523375; -.
DR   GuidetoPHARMACOLOGY; 1352; -.
DR   iPTMnet; Q86W10; -.
DR   PhosphoSitePlus; Q86W10; -.
DR   BioMuta; CYP4Z1; -.
DR   DMDM; 48428052; -.
DR   EPD; Q86W10; -.
DR   jPOST; Q86W10; -.
DR   MassIVE; Q86W10; -.
DR   PaxDb; Q86W10; -.
DR   PeptideAtlas; Q86W10; -.
DR   ProteomicsDB; 70100; -.
DR   Antibodypedia; 32850; 164 antibodies from 26 providers.
DR   DNASU; 199974; -.
DR   Ensembl; ENST00000334194.4; ENSP00000334246.3; ENSG00000186160.5.
DR   GeneID; 199974; -.
DR   KEGG; hsa:199974; -.
DR   MANE-Select; ENST00000334194.4; ENSP00000334246.3; NM_178134.3; NP_835235.1.
DR   UCSC; uc001cqu.2; human.
DR   AGR; HGNC:20583; -.
DR   CTD; 199974; -.
DR   DisGeNET; 199974; -.
DR   GeneCards; CYP4Z1; -.
DR   HGNC; HGNC:20583; CYP4Z1.
DR   HPA; ENSG00000186160; Tissue enhanced (breast).
DR   MIM; 618953; gene.
DR   neXtProt; NX_Q86W10; -.
DR   OpenTargets; ENSG00000186160; -.
DR   PharmGKB; PA134941057; -.
DR   VEuPathDB; HostDB:ENSG00000186160; -.
DR   eggNOG; KOG0157; Eukaryota.
DR   GeneTree; ENSGT00940000160927; -.
DR   HOGENOM; CLU_001570_5_1_1; -.
DR   InParanoid; Q86W10; -.
DR   OMA; LHHNDLV; -.
DR   OrthoDB; 1611592at2759; -.
DR   PhylomeDB; Q86W10; -.
DR   TreeFam; TF105088; -.
DR   PathwayCommons; Q86W10; -.
DR   BioGRID-ORCS; 199974; 18 hits in 1142 CRISPR screens.
DR   GeneWiki; CYP4Z1; -.
DR   GenomeRNAi; 199974; -.
DR   Pharos; Q86W10; Tchem.
DR   PRO; PR:Q86W10; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q86W10; protein.
DR   Bgee; ENSG00000186160; Expressed in calcaneal tendon and 91 other tissues.
DR   Genevisible; Q86W10; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0008404; F:arachidonic acid 14,15-epoxygenase activity; IDA:UniProtKB.
DR   GO; GO:0070330; F:aromatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052722; F:fatty acid in-chain hydroxylase activity; IDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0019369; P:arachidonic acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0048252; P:lauric acid metabolic process; IDA:UniProtKB.
DR   CDD; cd20678; CYP4B-like; 1.
DR   Gene3D; 1.10.630.10; Cytochrome P450; 1.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   InterPro; IPR036396; Cyt_P450_sf.
DR   PANTHER; PTHR24291:SF63; CYTOCHROME P450 4X1-RELATED; 1.
DR   PANTHER; PTHR24291; CYTOCHROME P450 FAMILY 4; 1.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; Cytochrome P450; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   Endoplasmic reticulum; Fatty acid metabolism; Heme; Iron; Lipid metabolism;
KW   Membrane; Metal-binding; Microsome; Monooxygenase; Oxidoreductase;
KW   Reference proteome; Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN           1..505
FT                   /note="Cytochrome P450 4Z1"
FT                   /id="PRO_0000051864"
FT   TOPO_DOM        1..9
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        10..30
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        31..505
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   BINDING         452
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000250"
FT   VARIANT         393
FT                   /note="P -> L (in dbSNP:rs28463559)"
FT                   /id="VAR_048461"
SQ   SEQUENCE   505 AA;  59086 MW;  CF23D96739402E86 CRC64;
     MEPSWLQELM AHPFLLLILL CMSLLLFQVI RLYQRRRWMI RALHLFPAPP AHWFYGHKEF
     YPVKEFEVYH KLMEKYPCAV PLWVGPFTMF FSVHDPDYAK ILLKRQDPKS AVSHKILESW
     VGRGLVTLDG SKWKKHRQIV KPGFNISILK IFITMMSESV RMMLNKWEEH IAQNSRLELF
     QHVSLMTLDS IMKCAFSHQG SIQLDSTLDS YLKAVFNLSK ISNQRMNNFL HHNDLVFKFS
     SQGQIFSKFN QELHQFTEKV IQDRKESLKD KLKQDTTQKR RWDFLDILLS AKSENTKDFS
     EADLQAEVKT FMFAGHDTTS SAISWILYCL AKYPEHQQRC RDEIRELLGD GSSITWEHLS
     QMPYTTMCIK ECLRLYAPVV NISRLLDKPI TFPDGRSLPA GITVFINIWA LHHNPYFWED
     PQVFNPLRFS RENSEKIHPY AFIPFSAGLR NCIGQHFAII ECKVAVALTL LRFKLAPDHS
     RPPQPVRQVV LKSKNGIHVF AKKVC
//
